Yasser Heakal, Ph.D.
Affiliations: | 2009 | Pennsylvania State University, State College, PA, United States |
Area:
PharmacologyGoogle:
"Yasser Heakal"Mean distance: 17811
Parents
Sign in to add mentor| Mark Kester | grad student | 2009 | Penn State | |
| (Identification of novel pharmacological approaches to inhibit neurotensin receptor -1 mitogenic signaling in breast cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Masso-Welch P, Girald Berlingeri S, King-Lyons ND, et al. (2018) LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and Necroptosis. International Journal of Molecular Sciences. 20 |
| Heakal Y, Kester M, Savage S. (2011) Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma. The Annals of Pharmacotherapy. 45: 1399-405 |
| Jiang Y, DiVittore NA, Kaiser JM, et al. (2011) Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biology & Therapy. 12: 574-85 |
| Heakal Y, Woll MP, Fox T, et al. (2011) Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains. Cancer Biology & Therapy. 12: 427-35 |
| Heakal Y, Kester M. (2009) Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells. Molecular Cancer Research : McR. 7: 724-34 |
| Kester M, Heakal Y, Fox T, et al. (2008) Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Letters. 8: 4116-21 |
| Zolnik BS, Stern ST, Kaiser JM, et al. (2008) Rapid distribution of liposomal short-chain ceramide in vitro and in vivo. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1709-15 |
| Jiang Y, Kaiser J, Heakal Y, et al. (2007) Growth inhibitory effect of ceramide-incorporated nanoliposomes in human pancreatic cancer cells Journal of Clinical Oncology. 25: 14105-14105 |